140 machine-learning-"https:" "https:" "https:" "https:" "https:" "UCL" positions at Leibniz in Germany
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
regulations. Further information on data protection and the processing of personal data can be found at: https://www.isas.de/en/datenschutz . The closing date for applications is March 25, 2026. Please apply
-
skills work together, in order to learn from one another and generate new knowledge and new methods to create a better quality of life in our world. DWI offers you a wide range of possibilities to develop
-
The Bernhard Nocht Institute for Tropical Medicine (https://www.bnitm.de/en/ ) is the largest Research Institute for Tropical Medicine in Germany and is the National Reference Centre for Tropical
-
consequences for essential ecosystem processes. In the framework of the Biodiversity Exploratories (https://www.biodiversity-exploratories.de/en/ ), funded by the German Research Foundation (DFG), the project
-
following through the online application system - https://www.leibniz-inm.de/en/job-offers-2/ Motivation letter CV (max 2 pages) Publication list Academic transcripts Contact details of 2-3 references
-
skills work together, in order to learn from one another and generate new knowledge and new methods to create a better quality of life in our world. DWI offers you a wide range of possibilities to develop
-
and experience or willingness to learn methods, in particular the morphological, chemical, and microbiological characterization of plant samples Very good knowledge of statistical data analysis and data
-
approach familiarity with the German academic system and the country’s policy landscape We appreciate your willingness to acquire German language skills. The University of Hamburg and the GIGA will provide
-
The Bernhard Nocht Institute for Tropical Medicine (https://www.bnitm.de/en ) is the largest Research Institute for Tropical Medicine in Germany and is the National Reference Centre for Tropical
-
vitro assays for different immunotherapeutic modalities, specifically focused on bispecific T cell engagers therapies and antibody-drug conjugates Isolate and culture primary human T cells to create CAR T